Trials / Conditions / Chronic Allograft Nephropathy

Chronic Allograft Nephropathy

11 registered clinical trials studyying Chronic Allograft Nephropathy.

Status	Trial	Sponsor	Phase
Completed	Validity of Strain Elastography for the Evaluation of Chronic Allograft Nephropathy NCT05682313	Kasr El Aini Hospital	N/A
Completed	Treatment of Autonomous Hyperparathyroidism in Post Renal Transplant Recipients NCT00975000	Amgen	Phase 3
Completed	Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients NCT01265615	Ural State Medical University	Phase 4
Unknown	Impact of Conversion From Tacrolimus to Sirolimus in African American Renal Transplant Recipients NCT00999258	Temple University	Phase 4
Completed	Effects of PGI2 Analogue Use on the Development of Chronic Allograft Nephropathy NCT01056835	Seoul National University Hospital	Phase 3
Completed	Study Cyclosporine (CsA) Versus Tacrolimus (Tacro) After Campath Induction in Kidney Transplantation NCT01346397	Russian Academy of Medical Sciences	—
Unknown	Mesenchymal Stem Cell Transplantation in the Treatment of Chronic Allograft Nephropathy NCT00659620	Fuzhou General Hospital	Phase 1 / Phase 2
Terminated	Value of Rituximab in Humoral Chronic Rejection After Renal Transplantation NCT00568477	Technical University of Munich	Phase 2
Unknown	Calcineurin Inhibitor Minimisation in Renal Transplant Recipients With Stable Allograft Function NCT00541814	University Hospital Birmingham	Phase 4
Completed	Antibody and Delayed Cyclosporine Versus Initial Cyclosporine Alone in Patients Receiving Kidney Transplants NCT00007787	National Institute of Allergy and Infectious Diseases (NIAID)	N/A
Completed	Prevention of Kidney Transplant Rejection NCT00005010	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 3